BB, L., YY, J., X, L., MM, Y., Q, M., DN, W., . . . F, X. (2025). Qingrehuoxue formula enhances anti-PD-1 immunotherapy in NSCLC by remodeling the tumor immune microenvironment via TREM2 signaling. BMC complementary medicine and therapies, 25(1), 270. https://doi.org/10.1186/s12906-025-05020-8
Chicago Style (17th ed.) CitationBB, Li, Jiang YY, Li X, Yu MM, Meng Q, Wang DN, Zang JM, and Xu F. "Qingrehuoxue Formula Enhances Anti-PD-1 Immunotherapy in NSCLC by Remodeling the Tumor Immune Microenvironment via TREM2 Signaling." BMC Complementary Medicine and Therapies 25, no. 1 (2025): 270. https://doi.org/10.1186/s12906-025-05020-8.
MLA (9th ed.) CitationBB, Li, et al. "Qingrehuoxue Formula Enhances Anti-PD-1 Immunotherapy in NSCLC by Remodeling the Tumor Immune Microenvironment via TREM2 Signaling." BMC Complementary Medicine and Therapies, vol. 25, no. 1, 2025, p. 270, https://doi.org/10.1186/s12906-025-05020-8.